EP Patent

EP2608788A1 — Polymorphs of saxagliptin hydrochloride and processes for preparing them

Assigned to Assia Chemical Industries Ltd · Expires 2013-07-03 · 13y expired

What this patent protects

The invention provides polymorphs of Saxagliptin hydrochloride, processes for preparing polymorphs of Saxagliptin hydrocliloride, and pharmaceutical compositions of polymorphs of Saxagliptin hydrochloride.

USPTO Abstract

The invention provides polymorphs of Saxagliptin hydrochloride, processes for preparing polymorphs of Saxagliptin hydrocliloride, and pharmaceutical compositions of polymorphs of Saxagliptin hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
EP2608788A1
Jurisdiction
EP
Classification
—
Expires
2013-07-03
Drug substance claim
No
Drug product claim
No
Assignee
Assia Chemical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.